Evaluating the impact of the COVID-19 pandemic on cancer control in Manitoba
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 202111WI1
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$347,119.68Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
N/A
Research Location
CanadaLead Research Institution
University of ManitobaResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Cancer is the leading cause of death in Canada. The cancer care system aims to lessen this burden by improving survival through screening, early detection and diagnosis, and timely, high quality treatment. However, the COVID-19 pandemic has had a significant impact on cancer care. In Manitoba, several interventions were implemented by CancerCare Manitoba (CCMB) (the provincial agency responsible for cancer screening and treatment) to keep cancer patients safe while continuing to provide excellent care. These interventions included changes to cancer screening programs, shifts from in-person visits to telephone visits, prioritizing the most critical cancer surgeries, and altering how chemotherapy and radiotherapy were delivered. The overall goal of this project is to understand how the COVID-19 pandemic and the interventions that were implemented to reduce its impact affected cancer services and outcomes such as survival in Manitoba.